Technology
Novel combination therapy approach to keep leukemia at bay – News-Medical.Net
In chronic leukemias, blocking the overactive kinase JAK2 by a targeted therapy approach is only mitigating the patients’ symptoms,…
In chronic leukemias, blocking the overactive kinase JAK2 by a targeted therapy approach is only mitigating the patients’ symptoms, but cannot truly change the course of the disease. A study by the University of Basel has shown that it may be possible to…
Continue Reading
-
General12 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business20 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business22 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business19 hours agoHere’s what analysts expect for the BHP share price in the coming year